Bendamustine for Leukemia: Market Outlook 2025-2033

agregó una foto Health

2025-06-24 09:03:23 -

As we step into 2024, the global Bendamustine Injection market is on an exciting upward trajectory, predicting a robust compound annual growth rate (CAGR) of approximately 5% as we move toward the early 2030s. This surge is largely fueled by the increasing incidence of hematologic cancers, including chronic lymphocytic leukemia, non-Hodgkin’s lymphoma, and multiple myeloma. The landscape...

0 Commentarios 0 Acciones 415 Views 0 Vista previa